Common Contracts
1 similar Manufacturing and Marketing Agreement contracts
Manufacturing and marketing agreement for Tekturna and Tekturna HCTManufacturing and Marketing Agreement • July 16th, 2024
PDL BioPharma announced that PDL has committed to an equity investment in Noden Pharma DAC, a new privately held company (Noden) that has executed a purchase agreement with Novartis AG (Novartis) to acquire exclusive worldwide rights to manufacture, market, and sell the branded prescription medicine product sold under the name Tekturna® and Tekturna HCT® in the United States and Rasilez® and Rasilez HCT® in the rest of the world.
